Name
anar31
Label
Anti-Arrhythmics, Class 3 (Sleep Heart Health Study Visit One (SHHS1))
Description

Participant taking ANTI-ARRHYTHMICS, CLASS 3 within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Anti-Arrhythmics, Class 3 (Sleep Heart Health Study Visit One (SHHS1)) vs Sleep Heart Health Study (SHHS) Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total 5,804 - - -
No 5,777 - - -
Yes 9 - - -
Unknown 18 - - -
Anti-Arrhythmics, Class 3 (Sleep Heart Health Study Visit One (SHHS1)) vs Age at Sleep Heart Health Study Visit One (SHHS1)
Visit 1
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 342 1,017 1,769 1,617 955 104 5,804
No 336 1,013 1,763 1,613 948 104 5,777
Yes - - 3 2 4 - 9
Unknown 6 4 3 2 3 - 18
Anti-Arrhythmics, Class 3 (Sleep Heart Health Study Visit One (SHHS1)) vs Gender of the participant
Visit 1
Male Female Total
Total 2,765 3,039 5,804
No 2,747 3,030 5,777
Yes 7 2 9
Unknown 11 7 18
Anti-Arrhythmics, Class 3 (Sleep Heart Health Study Visit One (SHHS1)) vs Race of the participant
Visit 1
White Black Other Total
Total 4,907 515 382 5,804
No 4,888 510 379 5,777
Yes 9 - - 9
Unknown 10 5 3 18